Kent Imaging has partnered with TVM Life Science Innovation II SCSp to expedite the global commercialization of its SnapshotNIR® product, a non-invasive tissue imaging technology that measures oxygen saturation.

Information on the Target

Kent Imaging Inc., based in Calgary, Alberta, is a pioneering company in the field of tissue imaging. The company specializes in developing innovative technologies that enhance the assessment of tissue health, particularly in relation to oxygenation. Its flagship product, SnapshotNIR®, employs near infrared light to accurately measure tissue oxygen saturation (StO2), a crucial indicator of tissue viability. This non-invasive technology has gained FDA clearance and is applicable in various medical contexts, including wound care, plastic and reconstructive surgery, and vascular surgery.

By providing a comprehensive picture of microcirculation, SnapshotNIR® not only aids in evaluating tissue health but also informs the healing potential of wounds or surgical sites. Kent Imaging aims to revolutionize the imaging landscape, particularly in areas where there is a significant need for improved patient outcomes and cost-effective healthcare solutions.

Industry Overview in Canada

The Canadian medical technology industry is characterized by a strong focus on innovation and a commitment to improving healthcare delivery. With a growing demand for advanced diagnostic